FLUENT Corp. (CNSX: FNT.U)
Health Care · Pharmaceuticals · US
$0.02
-20.00% today · -69.2% 1Y
FLUENT Corp. (CNSX: FNT.U) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.76M.
Over the last twelve months the share price has lost 69.2%, trading between 0.02 and 0.08.
Tweenvest scores FLUENT Corp. across four factors: quality 33/100, value 59/100, growth 64/100. Its strongest factor is growth.
FNT.U price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.76M
- Revenue (TTM)
- $75.98M
- P/E
- —
- EPS
- -0.13
- Dividend yield
- —
- Beta (5Y)
- 0.77
- 52-week high
- $0.08
- 52-week low
- $0.02
- Avg volume (3M)
- —
- Shares outstanding
- 637.97M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Indo-Bangla Pharmaceuticals LimitedDSE: IBP | $13.02M | Tk13.80 | -5.48% |
| Silco Pharmaceuticals LimitedDSE: SILCOPHL | $12.90M | Tk15.30 | -8.38% |
| Anebulo Pharmaceuticals, Inc.OTCPK: ANEB | $12.85M | $0.32 | -1.56% |
| Intravenous Infusions PlcGHSE: IIL | $12.84M | GH₵0.55 | +12.24% |
| Biogened S.A.WSE: BGD | $12.41M | zł19.90 | +0.51% |
| Krebs Biochemicals & Industries LimitedBSE: 524518 | $12.41M | Rs55.72 | -19.71% |
| Liven Pharma LimitedKASE: LIVEN | $12.40M | PKRs30.37 | -2.47% |
| Alpa Laboratories LimitedNSEI: ALPA | $12.39M | Rs56.99 | -3.83% |
Figures last refreshed Oct 11, 2026.